BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

HitGen , MTPC to discover novel hit compounds for multiple drug targets

During the three-year collaboration, multiple undisclosed targets (including undruggable targets) were screened against HitGen's proprietary DNA encoded ch...

February 25, 2022 | News

Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

JAB-21822 in combination with cetuximab for the treatment of KRAS G12C-mutated advanced colorectal cancer. Colorectal cancer is the second most common tumo...

February 24, 2022 | News

Mevion Selected to Equip Proton Therapy Center at Tongji Hospital in China

The system at Tongji Hospital will feature Mevion’s industry leading HYPERSCAN® Pencil Beam Scanning (PBS) technology, coupled with the industry&...

February 23, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China

According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...

February 21, 2022 | News

Catalent Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China

The facility will be expanded by approximately 30,000 square feet (approximately 2,800 square meters), which will double the clinical storage capacity...

February 16, 2022 | News

Kintor Pharma Announces First Patient Dosing in China

Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...

February 14, 2022 | News

WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories

For the 2022 CMO Leadership Awards, Life Science Leader Magazine teamed up with Industry Standard Research (ISR) to conduct the Contract Manufacturing Qual...

February 11, 2022 | News

IsoPlexis opens first APAC office

IsoPlexis, the Superhuman Cell Company, today announced the opening of its first office in the Asia-Pacific (APAC) region headed by Jason Ou as President/G...

February 03, 2022 | News

Reaction Biology Announces Integrated Drug Discovery Solution

The Reaction Oncology Platform is based on a network of strategic partners, including oncology and biophysics by the US and Germany-based Reaction Biology,...

February 03, 2022 | News

ImmVira's New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors

Solid tumor has long been a challenge for CAR-T. Major obstacles include solid tumor heterogeneity, lack of tumor associated antigens as CAR-T targets, com...

January 25, 2022 | News

WuXi STA Launches its First Parenteral Formulation Manufacturing Line

The industry-leading automatic parenteral filling line features multiple filling modules and a built-in lyophilizer to fill vials, syringes, and ...

January 24, 2022 | News

GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector

On January 19, 2022, GenScript ProBio broke ground for the construction of its newest plasmid and viral vector manufacturing facility, a 34,000-square...

January 21, 2022 | News

Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings

Clinical Stage Asset Has Potential for First Approved Oral Therapy for Leber's Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP) Caused by Mutatio...

January 20, 2022 | News

NextSmartShip Solution for B2B E-commerce Platforms to Extend Global Reach

NextSmartShip, a world-leading fulfillment service provider for global e-commerce sellers, signed a strategic partnership agreement with LyncMed...

January 14, 2022 | News

Stay Connected